Literature DB >> 10955378

Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis.

P Faggiano1, F Antonini-Canterin, F Ribichini, A D'Aloia, V Ferrero, E Cervesato, D Pavan, C Burelli, G Nicolosi.   

Abstract

Pulmonary hypertension (PH) has been reported in patients with valvular aortic stenosis (AS) and has been found to be associated with a more severe clinical picture and a poor prognosis after aortic valve replacement. The aim of this study was to assess the prevalence of PH in adult patients with symptomatic AS undergoing cardiac catheterization, and to evaluate the relation between pulmonary artery (PA) systolic pressure and hemodynamic and clinical variables to further clarify the pathogenetic mechanisms. We assessed right-sided heart hemodynamics during cardiac catheterization in 388 patients with symptomatic isolated or predominant AS. PA systolic pressure between 31 and 50 mm Hg was used to define mild to moderate PH, whereas PA systolic pressure >50 mm Hg was used to define severe PH. PA systolic pressure showed no significant difference according to age and sex, although it was significantly higher in patients in New York Heart Association functional classes III and IV and in patients with coexistent systemic hypertension than in the others. PH was absent in 136 patients (35%, group 1), mild to moderate in 196 patients (50%, group 2), and severe in 58 patients (15%, group 3). Only the prevalence of overt heart failure was significantly higher in group 3 patients. AS severity was similar among the 3 groups, and PA systolic pressure showed no relation to aortic valve area in the entire population. Also, a poor correlation was found between PA pressure and left ventricular (LV) ejection fraction (r = -0.28), with several patients having moderate or severe PH despite a preserved LV systolic function. PA systolic pressure significantly correlated with LV end-diastolic pressure (r = 0.50) and with PA wedge pressure (r = 0.84). Furthermore, transpulmonary pressure gradient, an index of resistance across the pulmonary vascular bed (obtained as the difference between PA mean and PA wedge pressure), was significantly higher in patients with PH, especially in those with a marked increase in PA systolic pressure, suggesting a reactive component of PH.

Entities:  

Mesh:

Year:  2000        PMID: 10955378     DOI: 10.1016/s0002-9149(99)00643-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  Impact of transcatheter aortic valve implantation (TAVI) on pulmonary hyper-tension and clinical outcome in patients with severe aortic valvular stenosis.

Authors:  Dimitry Schewel; Jury Schewel; Julia Martin; Lisa Voigtländer; Christian Frerker; Peter Wohlmuth; Thomas Thielsen; Karl-Heinz Kuck; Ulrich Schäfer
Journal:  Clin Res Cardiol       Date:  2014-11-04       Impact factor: 5.460

2.  Left atrial dysfunction as a determinant of pulmonary hypertension in patients with severe aortic stenosis and preserved left ventricular ejection fraction.

Authors:  Andreea Calin; Anca D Mateescu; Monica Rosca; Carmen C Beladan; Roxana Enache; Simona Botezatu; Iulian Cosei; Cosmin Calin; Marian Simion; Carmen Ginghina; Andreea C Popescu; Bogdan A Popescu
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-15       Impact factor: 2.357

3.  Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis.

Authors:  Brian R Lindman; Alan Zajarias; José A Madrazo; Jay Shah; Brian F Gage; Eric Novak; Stephanie N Johnson; Murali M Chakinala; Tara A Hohn; Mohammed Saghir; Douglas L Mann
Journal:  Circulation       Date:  2012-03-25       Impact factor: 29.690

Review 4.  Current management of calcific aortic stenosis.

Authors:  Brian R Lindman; Robert O Bonow; Catherine M Otto
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

5.  Determinants of pulmonary hypertension development in moderate or severe aortic stenosis.

Authors:  Hyo-Suk Ahn; Sung-A Chang; Hyung-Kwan Kim; Seon Jin Kim; Seung-Pyo Lee; Sung-Ji Park; Yong-Jin Kim; Goo-Yeong Cho; Dae-Won Sohn; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2014-07-22       Impact factor: 2.357

Review 6.  Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure.

Authors:  Thenappan Thenappan; Mardi Gomberg-Maitland
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 7.  Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.

Authors:  B R Lindman; M M Chakinala
Journal:  Int J Clin Pract Suppl       Date:  2010-11

8.  Pulmonary hypertension is a manifestation of congestive heart failure and left ventricular diastolic dysfunction in octogenarians with severe aortic stenosis.

Authors:  Amresh Raina; Zachary M Gertz; William T O'Donnell; Howard C Herrmann; Paul R Forfia
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 9.  Cardiac causes of pulmonary arterial hypertension: assessment with multidetector CT.

Authors:  Edward T D Hoey; Deepa Gopalan; S K Bobby Agrawal; Nicholas J Screaton
Journal:  Eur Radiol       Date:  2009-05-27       Impact factor: 5.315

10.  Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement.

Authors:  Brian R Lindman; Alan Zajarias; Hersh S Maniar; D Craig Miller; Rakesh M Suri; Suzanne V Arnold; John Webb; Lars G Svensson; Susheel Kodali; Ke Xu; Girma M Ayele; Fay Lin; Shing-Chiu Wong; Vasilis Babaliaros; Vinod H Thourani; Pamela S Douglas; Scott Lim; Martin B Leon; Michael J Mack
Journal:  Heart       Date:  2015-08-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.